Anil Vij took only first of double-dose Covid-19 vaccine: Health Ministry

In the case of this vaccine, trial volunteers receive two intramuscular injections approximately 28 days apart.

Anil Vij
File photo of Haryana Health Minister Anil Vij | Photo: Twitter@ANI
IANS New Delhi
2 min read Last Updated : Dec 05 2020 | 2:21 PM IST

Just hours after Haryana Health Minister Anil Vij, who was administered a dose of Covaxin last month, confirmed he has developed Coronavirus symptoms, the Union Health Ministry on Saturday clarified that Vij took only the first dose of the two-dose vaccine.

"The antibodies against the infection build up in a human being only after a specific number of days pass after the second dose of the vaccine is taken. Since, this is a two-dose vaccine. Minister in question has taken only one dose of the vaccine," the ministry said in a statement.

In the case of this vaccine, trial volunteers receive two intramuscular injections approximately 28 days apart.

Participants are randomly assigned to receive Covaxin or placebo. The trial is double-blinded, such that the investigators, the participants and the company are not aware of who is assigned to which group.

The statement from the ministry came after the 67-year-old minister tested positive two weeks after being given a shot of the vaccine, which is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research, at a hospital in Ambala as part of the third phase of the trial.

"I have been tested Corona positive. I am admitted in Civil Hospital Ambala Cantt. All those who have come in close contact to me are advised to get themselves tested for corona," Vij tweeted on Saturday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusAnil VijCoronavirus VaccineHaryana

First Published: Dec 05 2020 | 1:30 PM IST

Next Story